HIGHLIGHTS
- who: Massimiliano Salati and colleagues from the Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy have published the article: IDH Signalling Pathway in Cholangiocarcinoma: From Biological Rationale to Therapeutic Targeting, in the Journal: (JOURNAL)
- what: The authors focused on the aberrant IDH signaling pathway, reviewing its biological relevance in cancer together with the preclinical and clinical development of selective IDH inhibitors as well as future perspectives in cholangiocarcinoma. This study provided an in-depth molecular characterization that went beyond the site of origin of CCA as, for instance, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.